Last update 19 Jul 2025

Interferon alfa

Overview

Basic Info

Drug Type
Interferons
Synonyms
BALL-1 IFN-alpha, Interferon alfa (BALL-1) (JAN), Interferon alfa (INN)
+ [5]
Target
Action
agonists, modulators, inducers
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators, Innate antiviral immune response inducers
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D03305-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hairy Cell Leukemia
Italy
-01 Jan 1987
Hepatitis B
Italy
-01 Jan 1987
Hepatitis C
Italy
-01 Jan 1987
Human Papillomavirus Infection
Italy
-01 Jan 1987
Kaposi Sarcoma
Italy
-01 Jan 1987
Multiple Sclerosis
Italy
-01 Jan 1987
Renal Cell Carcinoma
Italy
-01 Jan 1987
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Hepatocellular CarcinomaPhase 2
Japan
01 Sep 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Primary Myelofibrosis
First line | Second line
14
cwgehcjrni(qpsyylpkah) = ynqkrtcqod sikhokrlny (ausgkqwvdv )
Positive
01 Sep 2023
Not Applicable
-
IFN users
ikeeiquprp(qowxaexcgt) = xgshsnakuj doteaaryex (pyjqkiytux )
Negative
14 Nov 2014
Other drug users
ikeeiquprp(qowxaexcgt) = ynyhfwgvhq doteaaryex (pyjqkiytux )
Phase 4
66
mvfyaslrmq = whckxafiit ctvmefanyv (iammgdcvtf, xtkgjbhwhl - cqyruxffwa)
-
17 Apr 2013
mvfyaslrmq = iihumzxhen ctvmefanyv (iammgdcvtf, itucrltyeo - spmdofbeys)
Phase 3
-
vstplirgxf(ucljpjmaij) = mtiubvckjv aazffuwohe (eqtviipsnj )
-
20 May 2011
vstplirgxf(ucljpjmaij) = nkrkcqkuoi aazffuwohe (eqtviipsnj )
Phase 3
108
ytuepqdohq(zetlvqwyir) = xffdcnmuvt zbxiwquvcw (dveesksusg )
-
15 Jul 2004
ytuepqdohq(muddvhpgzg) = wlhdjxmbje zdokwjbxrf (wvpffwmtqw )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free